دورية أكاديمية

Variable carbohydrate modifications to the catalytic chains of the RgpA and RgpB proteases of Porphyromonas gingivalis W50.

التفاصيل البيبلوغرافية
العنوان: Variable carbohydrate modifications to the catalytic chains of the RgpA and RgpB proteases of Porphyromonas gingivalis W50.
المؤلفون: Curtis MA; MRC Molecular Pathogenesis Group, Department of Oral Microbiology, St. Bartholomew's and the Royal London School of Medicine and Dentistry, Queen Mary and Westfield College, London E1 2AA, United Kingdom. M.A.Curtis@mds.qmw.ac.uk, Thickett A, Slaney JM, Rangarajan M, Aduse-Opoku J, Shepherd P, Paramonov N, Hounsell EF
المصدر: Infection and immunity [Infect Immun] 1999 Aug; Vol. 67 (8), pp. 3816-23.
نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't
اللغة: English
بيانات الدورية: Publisher: American Society For Microbiology Country of Publication: United States NLM ID: 0246127 Publication Model: Print Cited Medium: Print ISSN: 0019-9567 (Print) Linking ISSN: 00199567 NLM ISO Abbreviation: Infect Immun Subsets: MEDLINE
أسماء مطبوعة: Publication: Washington, DC : American Society For Microbiology
Original Publication: [Bethesda, Md.] American Society for Microbiology.
مواضيع طبية MeSH: Carbohydrates/*chemistry , Cysteine Endopeptidases/*chemistry , Endopeptidases/*chemistry , Hemagglutinins/*chemistry , Porphyromonas gingivalis/*enzymology, Adhesins, Bacterial ; Animals ; Antibodies, Monoclonal/immunology ; Catalytic Domain ; Cysteine Endopeptidases/immunology ; Endopeptidases/immunology ; Female ; Gingipain Cysteine Endopeptidases ; Glycosylation ; Hemagglutinins/immunology ; Lipopolysaccharides/chemistry ; Mice ; Mice, Inbred BALB C
مستخلص: Proteases of Porphyromonas gingivalis are considered to be important virulence determinants of this periodontal bacterium. Several biochemical isoforms of arginine-specific proteases are derived from rgpA and rgpB. HRgpA is a heterodimer composed of the catalytic alpha chain noncovalently associated with a beta adhesin chain derived from the C terminus of the initial full-length translation product. The catalytic alpha chain is also present as a monomer (RgpA) either free in solution or associated with membranes. rgpB lacks the coding region for the adhesin domain present in rgpA and yields only monomeric forms (RgpB) which again may be soluble or membrane associated. In this study, the catalytic chains of this unusual group of enzymes are shown to be differentially modified by the posttranslational addition of carbohydrate. A monoclonal antibody (MAb 1B5) raised to the monomeric RgpA did not react with the corresponding recombinant RgpA alpha chain expressed in Escherichia coli but was immunoreactive with P. gingivalis lipopolysaccharide. MAb 1B5 also reacted with the membrane-associated forms of RgpA and RgpB but not with the heterodimeric HRgpA and the soluble form of RgpB. RgpA treated with denaturants was capable of binding to MAb 1B5 whereas treatment with periodate abolished this binding, suggesting the presence of carbohydrate residues within the epitope. Chemical deglycosylation abolished immunoreactivity with MAb 1B5 and caused a approximately 30% reduction in the size of the membrane-associated enzymes. Monosaccharide analysis of HRgpA and RgpA demonstrated 2.1 and 14.4%, respectively, carbohydrate by weight of protein. Furthermore, distinct differences were detected in their monosaccharide compositions, indicating that these protease isoforms are modified not only to different extents but also with different sugars. The variable nature of these additions may have a significant effect on the structure, stability, and immune recognition of these protease glycoproteins.
References: J Immunol. 1995 May 15;154(10):5331-7. (PMID: 7730636)
Mol Biotechnol. 1994 Aug;2(1):45-60. (PMID: 7866868)
J Biol Chem. 1995 Jun 2;270(22):13197-203. (PMID: 7768917)
Clin Exp Immunol. 1997 Nov;110(2):285-91. (PMID: 9367414)
J Biol Chem. 1998 Aug 21;273(34):21648-57. (PMID: 9705298)
Infect Immun. 1998 Sep;66(9):4108-14. (PMID: 9712755)
Microbiology. 1998 Sep;144 ( Pt 9):2487-96. (PMID: 9782496)
Nature. 1970 Aug 15;227(5259):680-5. (PMID: 5432063)
Nature. 1975 Aug 7;256(5517):495-7. (PMID: 1172191)
Proc Natl Acad Sci U S A. 1976 Aug;73(8):2687-91. (PMID: 1066681)
Anal Biochem. 1981 Nov 15;118(1):197-203. (PMID: 6175245)
J Bacteriol. 1983 Aug;155(2):831-8. (PMID: 6409884)
Methods Enzymol. 1983;101:347-62. (PMID: 6350817)
J Med Microbiol. 1985 Feb;19(1):85-94. (PMID: 3968707)
Gene. 1985;33(1):103-19. (PMID: 2985470)
Infect Immun. 1985 Nov;50(2):467-71. (PMID: 3902645)
J Bacteriol. 1985 Dec;164(3):1071-80. (PMID: 3905764)
Infect Immun. 1986 Aug;53(2):435-7. (PMID: 3525416)
J Clin Periodontol. 1986 Jul;13(6):570-7. (PMID: 3462204)
Gene. 1986;48(1):119-31. (PMID: 3549457)
J Biol Chem. 1989 Jan 15;264(2):1027-35. (PMID: 2910842)
Anal Biochem. 1989 Aug 1;180(2):195-204. (PMID: 2510544)
J Clin Periodontol. 1990 Jan;17(1):1-13. (PMID: 2404030)
FEBS Lett. 1991 Mar 25;280(2):195-8. (PMID: 2013312)
Eur J Biochem. 1991 Aug 1;199(3):647-52. (PMID: 1868849)
J Bacteriol. 1992 Apr;174(7):2236-40. (PMID: 1551844)
J Biol Chem. 1992 Sep 15;267(26):18902-7. (PMID: 1527018)
Immunol Lett. 1993 Feb;35(2):191-6. (PMID: 7685319)
J Gen Microbiol. 1993 May;139(5):949-55. (PMID: 8393070)
Microbiology. 1995 May;141 ( Pt 5):1247-54. (PMID: 7773418)
Infect Immun. 1995 Dec;63(12):4744-54. (PMID: 7591131)
Mol Microbiol. 1995 Sep;17(6):1201-14. (PMID: 8594338)
J Bacteriol. 1996 May;178(10):2876-82. (PMID: 8631676)
Infect Immun. 1996 Jul;64(7):2532-9. (PMID: 8698476)
EMBO J. 1996 Jul 15;15(14):3547-54. (PMID: 8670858)
J Clin Invest. 1996 Dec 15;98(12):2813-8. (PMID: 8981929)
Mol Microbiol. 1997 Mar;23(5):955-65. (PMID: 9076732)
J Periodontal Res. 1997 Jan;32(1 Pt 2):133-9. (PMID: 9085223)
Biochem J. 1997 May 1;323 ( Pt 3):701-9. (PMID: 9169603)
J Dent Res. 1997 Jun;76(6):1260-70. (PMID: 9168859)
Infect Immun. 1997 Jun;65(6):2218-24. (PMID: 9169754)
Methods Mol Biol. 1993;14:119-29. (PMID: 8348228)
FEBS Lett. 1993 Oct 11;332(1-2):197-201. (PMID: 8405442)
J Biol Chem. 1993 Nov 15;268(32):23780-3. (PMID: 8226911)
FEMS Immunol Med Microbiol. 1993 Oct;7(3):211-22. (PMID: 8275052)
J Clin Invest. 1994 Jul;94(1):361-7. (PMID: 8040277)
J Biol Chem. 1994 Aug 19;269(33):21371-8. (PMID: 8063764)
Mol Microbiol. 1993 Nov;10(4):781-7. (PMID: 7934840)
J Periodontal Res. 1994 Sep;29(5):339-47. (PMID: 7528274)
Arch Biochem Biophys. 1995 Feb 1;316(2):917-25. (PMID: 7864651)
Biochem Soc Trans. 1995 Feb;23(1):1-25. (PMID: 7758655)
المشرفين على المادة: 0 (Adhesins, Bacterial)
0 (Antibodies, Monoclonal)
0 (Carbohydrates)
0 (Gingipain Cysteine Endopeptidases)
0 (Hemagglutinins)
0 (Lipopolysaccharides)
EC 3.4.- (Endopeptidases)
EC 3.4.22.- (Cysteine Endopeptidases)
EC 3.4.99.- (arginine protease)
تواريخ الأحداث: Date Created: 19990723 Date Completed: 19990812 Latest Revision: 20221006
رمز التحديث: 20231215
مُعرف محوري في PubMed: PMC96659
DOI: 10.1128/IAI.67.8.3816-3823.1999
PMID: 10417143
قاعدة البيانات: MEDLINE
الوصف
تدمد:0019-9567
DOI:10.1128/IAI.67.8.3816-3823.1999